poisar

Stock

Arcadia Biosciences, Inc. RKDA

$0.51+6.25%

Overview

RKDA market data

Price History

RKDA price chart · 1M
O
0.504600
H
0.506900
L
0.504600
C
0.506900
Vol
617.00
Source
US equities market feed
Observed
Aug 26, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$0.50
Previous Close
$0.48
Day High
$0.51
Day Low
$0.50
52 Week High
$1.92
52 Week Low
$0.40
7 Day Return
+14.17%
30 Day Return
-23.45%
90 Day Return
-46.01%
1 Year Return
-53.92%
Daily Notional Volume
$312.8
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.71
Diluted earnings per share over the trailing twelve months.
Beta
0.52
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-195.9%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.38 – $6.71
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $1.4M · P/B 0.66 · P/S 0.30.

Company News

4 captured
Arcadia Biosciences shares are trading higher after the company reported a year-over-year increase in its Q2 EPS results.Benzinga · Aug 13, 2026, 8:30 PM
Arcadia Biosciences Q2 EPS $(2.09) Up From $(3.26) YoY, Sales $1.443M Down From $1.455M YoYBenzinga · Aug 13, 2026, 8:25 PM
8-K filing — Arcadia Biosciences, Inc. (RKDA)SEC EDGAR · Aug 13, 2026, 8:10 PM
Arcadia Biosciences Files Prospectus Pursuant To Which Selling Stockholders May Offer Up To 11.92M Shares Of Common Stock For ResaleBenzinga · Jun 26, 2026, 8:45 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock